Printer Friendly

Browse Antineoplastic agents topic

Dosage and administration subtopic



1-112 out of 112 article(s)
Title Author Type Date Words
Neoplastic causes of nonacute facial paralysis: a review of 221 cases. Leonetti, John P.; Marzo, Sam J.; Anderson, Douglas A.; Sappington, Joshua M. Report Sep 1, 2016 2608
Immune-modulating cancer drugs finally get some respect. Faloon, Chancellor Jun 1, 2016 4060
Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres. Ko, Jenny J.; Asif, Tehmina; Li, Haocheng; Alimohamed, Nimira; Nguyen, Phuong Thao; Heng, Daniel Y.C Report May 1, 2016 4521
ICON: improving care of human health using intelligent data mining. Kiruba, S. Arul; Pavithra, V.; Saranya, A.; Dharani, B. Report Feb 1, 2016 3464
Resveratrol, quercetin could improve safety of cancer drug. Brief article Nov 1, 2015 172
Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells. Kim, Kyung-Ho; Kim, Ji-Yun; Kwak, Jong-Hwan; Pyo, Suhkneung Report Aug 15, 2015 5928
New cancer drugs can wake up sleeping killer T cells: frontline immune system fighters, often evaded by tumors, might now resume the attack. Seppa, Nathan Jul 11, 2015 1503
Norcantharidin derivatives as inhibitors in the development of breast cancer drugs. Patel, Darshil M. Report Apr 1, 2015 519
Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. Satelli, Arun; Brownlee, Zachary; Mitra, Abhisek; Meng, Qing H.; Li, Shulin Report Jan 1, 2015 4915
The joint effects of a chemotherapeutic agent and hematopoietic agent on stem cell production. Mouser, Christina L.; Antoniou, Eliana Report Mar 22, 2014 1617
A phase I dose-escalation study of oral BR-DIM (bioresponse 3,3'- diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Dec 1, 2013 347
Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast[R]) on colon adenocarcinoma (HT29) cells in vitro. Bonaterra, G.A.; Kelber, O.; Weisr, D.; Kinscherf, R. Report Jun 15, 2013 6414
Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. Morita, Jun; Naoe, Michio; Ogawa, Yu; Nakasato, Takehiko; Sugahara, Motoko; Morita, Masashi; Fuji, K Clinical report May 1, 2013 2385
Scientists in North saving young lives; Cancer drug dosages raised after research. Jan 17, 2013 728
The down side of cancer salves. Brief article Oct 1, 2012 230
High-Dose Vitamin C Reduces Inflammation in Cancer Patients Study Shows. Sep 25, 2012 620
Hodgkin's lymphoma with leptomeningeal involvement / Leptomeningeal Tutulumlu Hodgkin Lenfoma. Yildirim, Rahsan; Gundogdu, Mehmet; Erdem, Fuat; Kiki, Ilhami; Gundogdu, Betul Case study Sep 1, 2012 2361
New immune-based cancer therapies. Klotter, Jule Aug 1, 2012 575
Alternative therapeutic approach to various cancers with combinations of chemotherapeutic drugs or vitamin C and D-fraction. Konno, Sensuke; Alexander, Bobby; Choudhury, Muhammad Clinical report Aug 1, 2012 2013
War on cancer. Moss, Ralph Apr 1, 2012 2170
New set of nanoparticles 'may accurately deliver cancer drugs to tumours'. Jan 20, 2012 481
War on Cancer: progress against chronic lymphocytic leukemia. Moss, Ralph Nov 1, 2011 2205
Recommendations for the management of adult chronic myeloid leukaemia in South Africa. Louw, V.J.; Dreosti, L.; Ruff, P.; Jogessar, V.; Moodley, D.; Novitzky, N.; Patel, M.; Schmidt, A.; Disease/Disorder overview Nov 1, 2011 4783
War on cancer: two new drugs emerge for melanoma. Moss, Ralph Oct 1, 2011 2311
Fast-track drugs. Klotter, Jule Aug 1, 2011 683
Post-chemo brain. Klotter, Jule Aug 1, 2011 460
Curcumin compound boosts head and neck cancer therapy. Dye, D. Brief article Aug 1, 2011 199
Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. Salminen, Kaisa A.; Meyer, Achim; Jerabkova, Lenka; Korhonen, Laura E.; Rahnasto, Minna; Juvonen, Ri Report Apr 15, 2011 4961
The case of the uncontrolled nausea and vomiting. Eisenberg, Seth Apr 1, 2011 308
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera (rituximab). Feb 16, 2011 1233
Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. Chanmahasathien, Wisinee; Ampasavate, Chadarat; Greger, Harald; Limtrakul, Pornngarm Report Jan 15, 2011 5854
Crizotinib shows promise against some types of NSCLC. McBride, Deborah Brief article Jan 1, 2011 270
ZEVALIN Demonstrates 35-Month Progression-Free Survival Benefit after Single Dose in Patients with Non-Hodgkin's Lymphoma. Dec 6, 2010 2200
Single Dose ZEVALIN in First-Ever Phase 2 Monotherapy Trial for Non-Hodgkin's Lymphoma Shows Significant and Durable Clinical Responses. Dec 6, 2010 1434
Recent developments in the early diagnosis and management of multiple sclerosis. Ross, Amy Perrin; Thrower, Ben W. Report Dec 1, 2010 8621
FDA delay of one drug causes 82,000 lost life-years. Faloon, William Nov 1, 2010 3988
Journal abstracts: metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Nov 1, 2010 311
Bar raised in metastatic prostate Ca treatment. Freeman, Sara Nov 1, 2010 898
In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. Huang, X.H.; Xiong, P.C.; Xiong, C.M.; Cai, Y.L.; Wei, A.H.; Wang, J.P.; Liang, X.F.; Ruan, J.L. Report Oct 1, 2010 5245
New foe for advanced melanoma: drug offers hope to half of patients with deadly skin cancer. Seppa, Nathan Brief article Sep 25, 2010 306
Agents show promise for basal cell carcinoma. Boschert, Sherry Sep 15, 2010 588
FDA Approves New Dosing for FASLODEX (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women. Sep 10, 2010 1254
Cellular assassin's surprise benefit; disabling killer protein might encourage repeated cancers. Saey, Tina Hesman Aug 28, 2010 455
FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation. Aug 5, 2010 2190
Jury hears of inmate's final hours; WARDER TELLS HOW PRISONER FEARED HE'D BEEN GIVEN WRONG DOSAGE. Jul 15, 2010 492
Man's horror end after cancer drug prescription error; PRISONER GIVEN WRONG DOSAGE OF POWERFUL CHEMOTHERAPY. Jul 14, 2010 918
B.C. inorganic chemists meet in Squamish. Leznoff, Daniel Jul 1, 2010 302
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE[R] (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma. Jan 4, 2010 1819
Good leukemia drug news. Seppa, Nathan Brief article Jan 2, 2010 106
Neuroblastoma, a childhood nerve cancer, proves sensitive to drug: compound allows body's own tumor suppressor to do its job. Seppa, Nathan Dec 5, 2009 374
Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors. Coetzee, Marius J.; Louw, Vernon J.; Gartrell, Kevin; Viljoen, Chris D. Report Dec 1, 2009 1441
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin[R]. Oct 22, 2009 907
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. Guillen, Ponce; Carrato, Alfredo Clinical report Oct 1, 2009 1431
Women with breast cancer lived significantly longer without their disease getting worse when treated with Germany's Bayer AG and Onyx Pharmaceuticals Inc's (Emeryville CA) cancer pill Nexavar, researchers said. Brief article Sep 28, 2009 249
Cancer drugs could help alcoholics. Brief article Jul 1, 2009 213
Few cancer breakthroughs reported at major meeting. Jun 8, 2009 331
Britain's healthcare cost-effectiveness watchdog has recommended Merck KGaA's drug Erbitux be used on the state health service for treating some colon cancer patients after surgery. Brief article Jun 8, 2009 219
3-Hydrogenkwadaphnine, a novel diterpene ester from Dendrostellera lessertii, its role in differentiation and apoptosis of KG1 cells. Yazdanparast, Razieh; Meshkini, Azadeh Report Mar 1, 2009 4066
Cytotoxic therapies to feel the sting of generics: cytotoxic therapy, or chemotherapy as it is commonly known, has been the cornerstone of cancer treatment for many years and involves the use of drugs that are toxic to all cells--including those that are perfectly healthy. While relatively effective, this leads to the unpleasant side-effects commonly associated with cytotoxic treatment, such as vomiting, nausea, alopecia and fatigue. Dick, Matthew Mar 1, 2009 790
Smart pumps help limit infusion errors. Eisenberg, Seth Brief article Mar 1, 2009 279
New cytotoxic drug guidelines. Brief article Nov 1, 2008 126
Treatment of gastro-oesophageal cancers: the need for international co-operation. Wong, Rachel; Cunningham, David Editorial Sep 1, 2008 1016
Why do nurses resist safe-handling behaviors? Wujcik, Debra M. Editorial Aug 1, 2008 472
Presidential campaign plans for universal health insurance: what they should cover--and won't Part 2. Cohen, Marcus A. Jul 1, 2008 3426
Roche Holding AG, the world's biggest maker of tumor drugs, said a late-stage study showed its Herceptin medicine helped slow the spread of breast cancer when combined with its chemotherapy treatment Xeloda. Brief article Jun 9, 2008 186
Targeted therapies in breast cancer. Peck, Rahul; Kularatne, Bihani; O'Brien, Ciara Report Jun 1, 2008 3839
Study clarifies role of antioxidants during radiation. Moss, Ralph W. May 1, 2008 2316
Drugs to treat age-related macular degeneration compared in trial. Mar 1, 2008 348
Prognostic and predictive molecular markers in colorectal cancer: inhibition of the epidermal growth factor receptor. Stohlmacher, Jan Mar 1, 2008 2117
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma: a randomized phase III trial. Rougier, Philippe Mar 1, 2008 1352
21-gene assay predicts recurrence in node-positive breast Ca. Sullivan, Michele G. Feb 1, 2008 622
Novel anticancer agents have autoimmune toxicities. Jancin, Bruce Feb 1, 2008 563
APP Pharmaceuticals Launches Granisetron Hydrochloride Injection, USP. Jan 17, 2008 467
Xanthus Receives Orphan Drug Designation for Oral Fludarabine for the Treatment of CLL. Jan 3, 2008 611
How much abuse should cancer patients have to take? Faloon, William Nov 1, 2007 5131
Novel cancer drug shows promise. Kiefer, Dale Brief article Oct 1, 2007 160
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer. Carrato, Alfredo; Guillen-Ponce, Carmen Sep 1, 2007 1374
Genotype-specific dosing may improve tolerance and anticancer activity. McBride, Deborah Brief article Sep 1, 2007 307
Targeted therapy for renal cell carcinoma: a new treatment paradigm. Hutson, Thomas E. Clinical report Jul 1, 2007 4954
Straight to the tumour. Reprint Jul 1, 2007 185
New Clinical Data on Oral Cancer Drug REVLIMID Presented at Two Major International Medical Meetings Reports Shift in Treatment Paradigm for Treating Patients Across All Ages and Stages of Multiple Myeloma. Jun 7, 2007 569
HER2-directed therapies. Crabb, Simon J.; Chia, Stephen K. Jun 1, 2007 6544
Angiogenesis and breast cancer. Gillmore, Roopinder; Miles, David Jun 1, 2007 2456
Conventional treatments: chemotherapy--a medical 'solution'. Bridgman, Karen E. Mar 22, 2007 5475
Inhibitory effect of pirfenidone on glioblastoma cell lines: implications for treatment of neurofibromatosis. Krishnan, Sunil; Goble, Jennie M.; Frederick, Lori A.; James, C. David; Uhm, Joon H.; Kaufmann, Scot Clinical report Mar 1, 2007 4297
Genentech Inc's. Brief article Feb 26, 2007 156
Drug-drug interactions in oncology: implications for general practice. Clinical report Feb 1, 2007 2090
Effects of Hydrocotyle sibthorpioides extract on transplanted tumors and immune function in mice. Yu, Farong; Yu, Fahong; McGuire, P.M.; Li, R.; Wang, R. Clinical report Feb 1, 2007 4012
MGI PHARMA Announces Publication of Phase 2 Data Describing Dacogen(TM) (Decitabine) for Injection in Blood. Jan 3, 2007 1343
Talactoferrin Alpha receives fast-track designation for the treatment of non-small cell lung cancer. McBride, Deborah Jan 1, 2007 603
Bacteria-based immune therapy targets liver metastases. Brief article Jan 1, 2007 255
IND for MDX-1401. Brief article Jan 1, 2007 170
Temsirolimus extends survival in renal cancer. Lowry, Fran Oct 15, 2006 376
High-dose tretinoin safe for skin ca prevention: irritation caused by the higher dose is usually mild and transient. Goldman, Erik Drug overview Jul 15, 2006 628
Cyclacel Begins Phase I Pharmacologic Study of Oral Sapacitabine in Patients with Advanced Leukemias. Jun 15, 2006 820
Callisto Receives Approvals from Three Clinical Research Sites to Advance Clinical Trial of Atiprimod; Institutional Review Board Approvals Enable Study of Anti-Cancer Drug Candidate at Higher Dosage Levels. Apr 12, 2006 723
Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia. Oo, Thein H. Dec 1, 2005 773
Phase I Study of High Dose Weekly ABRAXANE(TM) Published in Journal of Clinical Oncology: Responses Achieved in Patients With Taxol(R) Refractory Ovarian Cancer and Lung Cancer. Nov 1, 2005 1171
Circulating tumor cells predict outcome in metastatic breast Ca. Apr 1, 2005 450
New Rx for chemotherapy-induced oral mucositis. Jancin, Bruce Apr 1, 2005 613
Safer way to curb local breast Ca recurrences. Jancin, Bruce Mar 15, 2005 595
Breast cancer surgery seems unaffected by menstrual timing. Mar 15, 2005 337
Rash often seen with new class of cancer drugs. Kirn, Timothy F. Mar 1, 2005 694
Low calcium, vitamin D intake rampant in breast cancer patients. Mar 1, 2005 498
Refined chemo helps in ER-negative breast Ca. Jancin, Bruce Mar 1, 2005 584
Oral glutamine curbs radiation dermatitis in breast cancer patients. Mar 1, 2005 628
Adjunctive chemotherapy adds benefit to tamoxifen in node-positive breast Ca. Mar 1, 2005 298
A chord-based method for computing alpha particle doses to the skeleton. Frederick, Steven; Jokisch, Derek W. Jan 1, 2005 138
Erlotinib, gefitinib nip lung cancer mortality. Goldman, Erik L. Sep 1, 2004 578
Fighting cancer with folate. Jul 1, 2002 410
No Evidence Adjusted-Dose Chemo Beats Fixed-Dose Prescribing. FINN, ROBERT Aug 1, 2001 352
Making polymers for surgical implants. Jun 16, 1990 295

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters